Drug Discovery Product Showcase

  1. Serum-Free, Xeno-Free Systems For Culture And Differentiation Of hMSCs 8/30/2022

    Sartorius offers a novel serum-free (SF) and xeno-free (XF) culture system as well as MSC NutriStem® media, which enable long-term growth of hMSCs from various sources while retaining self-renewal and multi-lineage differentiation potential.

  2. Cell Therapy Product Characterization Services 8/29/2022

    Our cell therapy product characterization services combine rapid PCR, ELISA and custom methods tailored to these product types from a single contract partner with fully compliant cGMP facilities and options for research grade testing available.

  3. Sartorius Cell Bank Manufacturing & Characterization Services 8/26/2022

    Utilizing our CRO expertise, our highly experienced team have expanded our service offering to include cell bank manufacturing as well as comprehensive biosafety testing services.

  4. Essential In Vivo Safety /Tox Studies To Move Your Molecule From Target To IND Successfully 7/28/2022

    For a molecule to progress smoothly from early-stage discovery to the IND phase and further to successful clinical trials, the data from preclinical trials must be accurate and reliable.

  5. Monoclonal Antibodies (mAbs) 2000 L 5 g/L Platform Accelerator℠ Integrated Solutions 7/20/2022

    Learn how we can help you select a process model that's perfect for you and ensure that it's adapted to meet your precise needs.

  6. Discovery Services: Putting Science To Work 6/29/2022

    Our Discovery Services span the entire spectrum of early-stage research from target identification to delivery of drug candidates for further development.

  7. Single-Use Supply Chain: The Distinct Advantage Of The Advanced Central Management System (ACMS) 6/6/2022

    This fully validated solution to support a Quality by Design approach to single-use assembly design and production. It ensures the delivery of high-quality, fit-for-purpose, single-use systems with strong documentation packages.

  8. ÄKTA oligosynt™ Oligonucleotide Synthesizer 3/28/2022

    The ÄKTA oligosynt™ oligonucleotide synthesizer is a compact, fully automated oligonucleotide synthesizer built for research and process development laboratories. The system supports a robust and easily scalable oligonucleotide synthesis process and transfer to larger oligonucleotide synthesizers with high yield and quality.

  9. Accelerator℠ Integrated Platform Solution for Adherent Lentivirus (LV) 3/25/2022

    Learn more about our end-to-end process support, from development to industrialization with a set of scalable solutions for lentivirus production.

  10. Digital Tech Transfer For Biopharma Manufacturing 3/11/2022

    We understand the complexity of knowledge transfer within the modern manufacturing network, including the collaboration with multiple CMOs. BIOVIA Discoverant is a validation-ready solution for digital tech transfer in manufacturing.